Team Technologies, a portfolio company of The Riverside Company, has acquired DoseLogix, a maker of metered dosing dispensers and applicators sold to patients, doctors and compounding pharmacists.
DoseLogix’s products, largely available under the Topi-CLICK brand, are used in the human and veterinary medical markets to accurately measure doses when applying topical medications, thereby improving compliance and outcomes of therapy. DoseLogix is based north of Atlanta in Woodstock, GA (www.doselogix.com).
Team Technologies is a contract manufacturer of consumable dental, cosmetic, and medical products sold to consumer packaged goods, retail, and private label customers. The company’s products include manual toothbrushes and power toothbrush heads; nail polish brushes; medicated eyelash applicators; disposable prophy angles and cups used for professional teeth cleanings; and surgical scrub brushes and swabs. The company is headquartered in Morristown, TN (www.teamtechinc.net).
“DoseLogix provides a unique solution to dosing challenges faced by compound pharmacies and end users,” said Riverside Managing Partner Suzy Kriscunas. “It continues to grow market share and has strong potential to expand into new treatment areas and build on its entry in veterinary medicine.”
The buy of DoseLogix is the second by Team Technologies since being acquired by Riverside in December 2012. In September 2014, it acquired Protexer (DBA BootieButler), a Knoxville, TN-based maker of shoe covers and dispenser.
“DoseLogix has plenty of room to continue expanding its market share in hormone replacement therapy while delivering similar great results for a wide array of other topical medications,” said Riverside Partner Ryan Richards. “Team Technologies is excited about the opportunity to partner with DoseLogix, and will focus on supporting growth, new product development, and maximizing cross-selling opportunities.”
The Riverside Company is a global private equity firm focused on investing in and acquiring growing businesses valued at up to $400 million. Since its founding in 1988, Riverside has invested in more than 530 transactions and its portfolio includes more than 80 companies. The firm is headquartered in New York with 16 additional US and international offices (www.riversidecompany.com).
Working with Ms. Kriscunas and Mr. Richards on this transaction were Vice President Jason Fulton, Associate Harrison Petts and Operating Partner George Benson. Origination Principal Jim Butterfield sourced the transaction for Riverside and Partner Anne Hayes helped secure the incremental financing.
© 2018 Private Equity Professional | May 22, 2018